| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.28B | 39.09B | 38.68B | 37.89B | 35.67B | 33.52B |
| Gross Profit | 7.28B | 7.24B | 7.08B | 6.61B | 6.60B | 6.33B |
| EBITDA | 3.46B | 3.65B | 3.40B | 3.06B | 3.26B | 3.13B |
| Net Income | 898.00M | 914.00M | 800.00M | 1.57B | 49.00M | 9.00M |
Balance Sheet | ||||||
| Total Assets | 84.65B | 85.61B | 83.30B | 82.04B | 81.60B | 82.68B |
| Cash, Cash Equivalents and Short-Term Investments | 6.35B | 5.90B | 5.37B | 5.00B | 5.08B | 6.45B |
| Total Debt | 26.53B | 26.82B | 25.25B | 24.94B | 25.03B | 28.22B |
| Total Liabilities | 49.82B | 50.37B | 49.21B | 48.68B | 49.79B | 50.82B |
| Stockholders Equity | 34.79B | 35.21B | 34.06B | 33.34B | 31.81B | 30.96B |
Cash Flow | ||||||
| Free Cash Flow | 464.00M | -835.00M | 755.00M | -59.00M | 2.42B | 447.00M |
| Operating Cash Flow | 703.00M | 2.11B | 3.55B | 1.11B | 2.99B | 2.77B |
| Investing Cash Flow | -272.50M | -2.77B | -2.70B | -682.00M | -654.00M | -2.34B |
| Financing Cash Flow | -392.50M | 1.07B | -509.00M | -579.00M | -3.79B | -509.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥165.51B | 9.78 | 10.24% | 2.43% | 6.08% | 8.55% | |
77 Outperform | ¥731.81B | 3.29 | 27.58% | 0.99% | 9.49% | 55.64% | |
75 Outperform | ¥117.48B | 15.30 | ― | 1.79% | 10.76% | 54.82% | |
72 Outperform | ¥13.52B | 4.54 | ― | 4.80% | 4.49% | 26.84% | |
66 Neutral | ¥137.07B | 17.53 | 2.80% | 3.38% | >-0.01% | -49.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥1.58T | 117.21 | 3.37% | 1.85% | -2.18% | 26.45% |